IPO & Deals
Listings, mergers, buyouts, venture and growth funding.
Page 3 of 21
- Pedestal AI emerges from stealth with $4.7 million seed round
Eclipse led the financing for the startup, which develops AI agents for supply chains and plans to expand its operations and deployments.
- Science Corporation raises $400 million at $3.5 billion valuation
The medical technology startup plans to use the Series D funding to pursue U.S. approval for its PRIMA vision device.
- Isomorphic Labs raises $5 billion in Series C for AI drug discovery
The company aims to bring drug candidates into clinical trials and will use the funding to develop its technology and explore more types of medicine.
- Genesis AI announces $500 million Series A
The robotics startup says it has produced 30 to 40 Eno humanoids and is conducting pilots with a handful of customers it has not named.
- Foxconn plans ¥7.24 billion purchase of Sony automotive camera business
The price remains subject to change as talks continue over additional assets, including overseas production equipment and inventory.
- Corma raises $125 million at $1 billion valuation
NEA led the cybersecurity AI startup’s Series A, bringing its total funding to $185 million about three months after its product debut.
- Serena Williams and Beth Ferreira launch venture firm seeking $200 million
Starfire Ventures will focus on early-stage AI-native businesses, while Serena Ventures has stopped making new investments.
- Flagship puts £100 million behind British AI biotech venture lab
The firm aims to draw at least £500 million from partners and initially recruit about 50 scientist-entrepreneurs and operators in Britain.
- Dreamteam secures $53 million to challenge established CRM providers
Accel and Together Fund led separate rounds for the startup, which says it has attracted more than 100 customers across 13 countries.
- Plural raises €1 billion for new venture funds
The capital will be split between early-stage investments and follow-on funding, with energy, AI infrastructure, defense and health among its targets.










